eMedonline access

BEHAVIORAL2 trials

Sponsors

Rex Cancer Center, Raleigh, NC

Conditions

Chronic Myeloid LeukemiaChronic Phase CML

Unknown Phase

Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy

TerminatedNCT01490775

Rex Cancer Center, Raleigh, NCChronic Phase CML

Start: 2009-04-30End: 2015-06-30Updated: 2018-08-13

Telemonitoring Study - for Chronic Myeloid Leukemia (CML)

TerminatedNCT01490983

Rex Cancer Center, Raleigh, NCChronic Myeloid Leukemia

Start: 2009-04-30End: 2014-12-31Updated: 2018-08-13